Correction to: Budget Impact Analysis of Fidaxomicin Versus Vancomycin for the Treatment of Clostridioides difficile Infection in the United States

Detalles Bibliográficos
Autores principales: Jiang, Yiling, Sarpong, Eric M., Sears, Pamela, Obi, Engels N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847657/
https://www.ncbi.nlm.nih.gov/pubmed/35034290
http://dx.doi.org/10.1007/s40121-021-00583-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847657/
https://www.ncbi.nlm.nih.gov/pubmed/35034290
http://dx.doi.org/10.1007/s40121-021-00583-8

Ejemplares similares